BOSTON, Mass., October 10, 2022 – Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today announced that Anne Prener, M.D., Ph.D., president and chief executive officer, Jai Patel, MRCP(UK), chief medical officer, and Komal Joshi, chief financial officer, will participate in BMO’s Fall Private Company Showcase, co-hosted with Solebury Trout and Goodwin, on October 13, 2022, in New York, NY.

For those attending the showcase, Dr. Prener will provide a corporate overview at 12:40pm EDT in Presentation Room 1 and senior management will participate in one-on-one meetings.